FORGIONE, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 444
EU - Europa 252
AS - Asia 148
AF - Africa 28
Totale 872
Nazione #
US - Stati Uniti d'America 440
IT - Italia 70
SG - Singapore 59
SE - Svezia 50
DE - Germania 44
CN - Cina 42
IE - Irlanda 27
IN - India 21
TG - Togo 19
GB - Regno Unito 18
VN - Vietnam 18
BG - Bulgaria 14
FI - Finlandia 8
CH - Svizzera 5
NG - Nigeria 5
BE - Belgio 4
CA - Canada 4
RU - Federazione Russa 4
ID - Indonesia 3
MK - Macedonia 3
CI - Costa d'Avorio 2
HR - Croazia 2
JO - Giordania 2
AT - Austria 1
FR - Francia 1
HK - Hong Kong 1
IQ - Iraq 1
MU - Mauritius 1
NL - Olanda 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 872
Città #
Chandler 70
Fairfield 64
Singapore 52
Santa Clara 42
Ashburn 27
Dublin 27
New York 24
Boardman 20
Lomé 19
Bologna 18
Dong Ket 18
Princeton 17
Sofia 14
Southend 14
Turin 13
Redmond 11
Cambridge 8
Helsinki 8
Lübeck 7
Rome 6
Seattle 6
Wilmington 6
Abeokuta 5
Berlin 4
Bern 4
Bremen 4
Brussels 4
Bühl 4
Houston 4
Ann Arbor 3
Falkenstein 3
Jakarta 3
Napoli 3
Palermo 3
Skopje 3
Washington 3
Woodbridge 3
Abidjan 2
Amman 2
Beijing 2
Frankfurt am Main 2
Nanjing 2
Ottawa 2
Portomaggiore 2
San Diego 2
Shenzhen 2
Springfield 2
Toronto 2
Zhengzhou 2
Amsterdam 1
Baghdad 1
Bari 1
Bra 1
Catania 1
Changzhou 1
Chicago 1
Correggio 1
Dallas 1
Des Moines 1
Fort Worth 1
Fuzhou 1
Guangzhou 1
Hounslow 1
Hyderabad 1
Jiangmen 1
Jinan 1
Langfang 1
Lianyun 1
London 1
Medford 1
Mogliano 1
Monmouth Junction 1
Mountain View 1
Muizenberg 1
Ningbo 1
Nuremberg 1
Nutley 1
Olalla 1
Prineville 1
Pune 1
Quanzhou 1
Shanghai 1
Shijiazhuang 1
Taizhou 1
Taranto 1
Tianjin 1
Vienna 1
Wanchai 1
Wenzhou 1
Westminster 1
Wuhan 1
Wuxi 1
Yuncheng 1
Totale 612
Nome #
Monofocal hepatocellular carcinoma: How much does size matter? 140
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 112
Anticoagulation in Cirrhotic Portal Vein Thrombosis: No Harm, but Survival Benefit Still Unclear 108
Pattern of macrovascular invasion in hepatocellular carcinoma 108
Experience with regorafenib in the treatment of hepatocellular carcinoma 69
Prognosis of Single Early-Stage Hepatocellular Carcinoma (HCC) with CEUS Inconclusive Imaging (LI-RADS LR-3 and LR-4) Is No Better than Typical HCC (LR-5) 66
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma 55
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib 52
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 39
An update on atezolizumab for hepatocellular carcinoma 33
Hepatocellular carcinoma in the non-cirrhotic liver 28
Contrast-enhanced ultrasound LI-RADS LR-5 in hepatic tuberculosis: Case report and literature review of imaging features 26
Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC 25
Contrast-Enhanced Ultrasound Features of Histopathologically Proven Hepatocellular Carcinoma in the Non-cirrhotic Liver: A Multicenter Study 22
Contrast-Enhanced Ultrasound LI-RADS LR-5 in Hepatic Tuberculosis: Case Report and Literature Review of Imaging Features 19
Totale 902
Categoria #
all - tutte 4.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 5 3 1 1 1
2020/202157 3 0 1 0 2 2 0 8 8 1 1 31
2021/2022215 2 0 1 3 13 6 11 28 14 21 91 25
2022/2023279 16 47 7 38 27 23 19 10 46 9 23 14
2023/2024131 8 23 5 10 7 52 6 7 5 5 3 0
2024/2025209 18 35 40 34 54 27 1 0 0 0 0 0
Totale 902